We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for vosoritide (BioMarin Pharmaceutical Australia Pty Ltd)
Active ingredients
vosoritide
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for injection
Indication
Treatment of achondroplasia in patients less than 2 years of age
Therapeutic area
Inherited bone disorder